Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- New Therapeutic GL for Arteriosclerotic Diseases Published
August 19, 2002
- ACNielsen, So-net M3 to Start Market Survey Service via MR-kun
August 19, 2002
- Shionogi to Collaborate with Oncotherapy Science for Genome-based Drug Discovery
August 19, 2002
- Chronic Heart Failure as Additional Indication Approved for Daiichi's Carvedilol
August 19, 2002
- Nippon Kayaku Developing DDS for Anticancer Drugs
August 19, 2002
- Toho Prepared for End Deals if Accord Not to Be Reached on Prices
August 19, 2002
- PRESS SEMINAR
August 19, 2002
- Ca Antagonists to Coexist with AII Antagonists
August 19, 2002
- Terumo's Hepaflush Prefilled Syringes Selling Well
August 19, 2002
- BUSINESS NEWS IN BRIEF
August 19, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 19, 2002
- AMO Japan Sees Split from Allergan as a Major Advantage: President Akedo
August 19, 2002
- OTC NEWS IN BRIEF
August 19, 2002
- Taisho, Toyama Agree to Form Capital, Business Alliance
August 19, 2002
- NEW PRODUCTS
August 19, 2002
- Olympus to Raise Sales to \870 Bil. in 5 Years
August 19, 2002
- MEETING
August 19, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
August 19, 2002
- MEDICAL DEVICE NEWS IN BRIEF
August 19, 2002
- To Further Concentrate on Ethical Drug Business: Takeda President
August 19, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…